CI
Conning Inc Portfolio holdings
AUM
$2.91B
1-Year Return
12.27%
This Quarter Return
-20.07%
1 Year Return
+12.27%
3 Year Return
+38.61%
5 Year Return
+77.33%
10 Year Return
+147.58%
AUM
$2.35B
AUM Growth
-$702M
(-23%)
Cap. Flow
-$160M
Cap. Flow
% of AUM
-6.8%
Top 10 Holdings %
Top 10 Hldgs %
20.44%
Holding
489
New
6
Increased
84
Reduced
263
Closed
66
Top Buys
| 1 |
Bristol-Myers Squibb
BMY
|
$39.1M |
| 2 |
AT&T
T
|
$34.2M |
| 3 |
Paychex
PAYX
|
$8.46M |
| 4 |
Nucor
NUE
|
$6.13M |
| 5 |
Valero Energy
VLO
|
$5.92M |
Top Sells
Sector Composition
| 1 | Consumer Staples | 14.63% |
| 2 | Technology | 12.33% |
| 3 | Healthcare | 11.74% |
| 4 | Financials | 11.1% |
| 5 | Industrials | 9.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
Booking.com
BKNG
$178B
| $961K | 0.04% |
714
-1
| -0.1% | -$1.35K |
|
152
Automatic Data Processing
ADP
$120B
| $957K | 0.04% |
7,000
-64
| -0.9% | -$8.75K |
|
153
Intuit
INTU
$188B
| $942K | 0.04% |
4,097
+24
| +0.6% | +$5.52K |
|
154
TJX Companies
TJX
$155B
| $926K | 0.04% |
19,373
-281
| -1% | -$13.4K |
|
155
Vertex Pharmaceuticals
VRTX
$102B
| $925K | 0.04% |
3,887
+7
| +0.2% | +$1.67K |
|
156
Becton Dickinson
BDX
$55.1B
| $919K | 0.04% |
4,100
-784
| -16% | -$176K |
|
157
Elevance Health
ELV
$70.6B
| $914K | 0.04% |
4,024
+15
| +0.4% | +$3.41K |
|
158
S&P Global
SPGI
$164B
| $891K | 0.04% |
3,637
-92
| -2% | -$22.5K |
|
159
Crown Castle
CCI
$41.9B
| $890K | 0.04% |
6,160
-161
| -3% | -$23.3K |
|
160
Duke Energy
DUK
$93.8B
| $879K | 0.04% |
10,871
-137
| -1% | -$11.1K |
|
161
Colgate-Palmolive
CL
$68.8B
| $877K | 0.04% |
13,214
-470
| -3% | -$31.2K |
|
162
CME Group
CME
$94.4B
| $871K | 0.04% |
5,040
-80
| -2% | -$13.8K |
|
163
Intuitive Surgical
ISRG
$167B
| $867K | 0.04% |
5,253
-297
| -5% | -$49K |
|
164
American Express
AXP
$227B
| $857K | 0.04% |
10,011
-293
| -3% | -$25.1K |
|
165
Southern Company
SO
$101B
| $841K | 0.04% |
15,530
-258
| -2% | -$14K |
|
166
Zoetis
ZTS
$67.9B
| $840K | 0.04% |
7,136
-183
| -3% | -$21.5K |
|
167
Equinix
EQIX
$75.7B
| $817K | 0.03% |
1,308
-89
| -6% | -$55.6K |
|
|
AGN
168
DELISTED
Allergan plc
AGN
| $817K | 0.03% |
4,615
-57
| -1% | -$10.1K |
|
169
Stryker
SYK
$150B
| $806K | 0.03% |
4,844
-103
| -2% | -$17.1K |
|
170
Archer Daniels Midland
ADM
$30.2B
| $788K | 0.03% |
22,402
-173,834
| -89% | -$6.11M |
|
171
Fiserv
FI
$73.4B
| $785K | 0.03% |
8,263
+416
| +5% | +$39.5K |
|
172
Chubb
CB
$111B
| $777K | 0.03% |
6,961
-277
| -4% | -$30.9K |
|
173
Northrop Grumman
NOC
$83.2B
| $772K | 0.03% |
2,550
-2
| -0.1% | -$605 |
|
174
iShares MSCI EAFE Growth ETF
EFG
$13.2B
| $747K | 0.03% |
10,507
| – | – |
|
175
Ross Stores
ROST
$49.4B
| $745K | 0.03% |
8,564
-208
| -2% | -$18.1K |
|